ACLARION, INC. Shares Outstanding (Cover Page)
ACLARION, INC. (ACON) had Shares Outstanding (Cover Page) of 2.88 million shares as of 2026-08-04, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-04: Entity Common Stock, Shares Outstanding 2.88M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 2.46M shares.
- 2026-03-17: Entity Common Stock, Shares Outstanding 2.28M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 671.37K shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-04 | 2.88M shares 10-Q · filed 2026-08-06 |
| 2026-05-11 | 2.46M shares 10-Q · filed 2026-05-13 |
| 2026-03-17 | 2.28M shares 10-K · filed 2026-03-18 |
| 2025-11-10 | 671.37K shares 10-Q · filed 2025-11-12 |
| 2025-08-14 | 582.37K shares 10-Q · filed 2025-08-14 |
| 2025-05-15 | 582.37K shares 10-Q · filed 2025-05-15 |
| 2025-04-09 | 582.37K shares 10-K · filed 2025-04-09 |
| 2024-11-14 | 10.43M shares 10-Q · filed 2024-11-14 |
| 2024-08-14 | 8.61M shares 10-Q · filed 2024-08-14 |
| 2024-05-15 | 8.20M shares 10-Q · filed 2024-05-15 |
| 2024-03-28 | 7.15M shares 10-K · filed 2024-03-28 |
| 2023-11-14 | 8.79M shares 10-Q · filed 2023-11-14 |
| 2023-08-25 | 8.20M shares 10-Q · filed 2023-08-25 |
| 2023-07-03 | 8.20M shares 10-Q · filed 2023-07-03 |
| 2023-06-09 | 8.20M shares 10-K/A · filed 2023-06-12 |
| 2023-02-27 | 7.86M shares 10-K · filed 2023-02-27 |
| 2022-11-14 | 7.82M shares 10-Q · filed 2022-11-14 |
| 2022-08-15 | 7.82M shares 10-Q · filed 2022-08-15 |
| 2022-06-06 | 7.82M shares 10-Q · filed 2022-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |